CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Unregistered share sale
- S-4 Deal Registration Statement - Business Combination
- 8-K Event Material agreement · Agreement ended
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Executive or director change · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 8-K Event Agreement ended
- 8-K Event Material agreement
- 10-K Report Annual Report
- 8-K Event Other events
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 26 of 54 · 1,070 filings